Bacterial and resistance profile related to surgical site infections in neurosurgery

• Autor(a) principal: Silva, Samyly Pereira da
• Data de Publicação: 2023
• Outros Autores: Prado, Ana Beatriz Barros Porpino do, Silva, Iago José Cunha, Leão, Marcos Lorran Paranhos, Viana, Amanda Carla Corrêa, Sales, Thiago Joanes Brandão, Oliveira, Fábio Henrique Cavalcanti de, Melo, Flávia Bezerra de Souza
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Scire Salutis
• Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/7564
• topic: Infecção hospitalar; Infecção da ferida cirúrgica; Resistência microbiana a medicamentos; Cross Infection; Surgical wound infection; Microbial drug resistance

Health care-related infections are an important adverse event related to patient safety and the number of occurrences has grown worldwide. When they occur at neurosurgical sites, these infections are usually associated with a poor prognosis and patient follow-up. Thus, the objective of this research was to identify the profile of the bacterial microbiota and the resistance to antibiotics used in patients undergoing neurological surgery. This is a descriptive, cross-sectional, retrospective study of a quantitative nature. The medical records of patients diagnosed with Surgical Site Infection (SSI), from July 2018 to December 2019, were analyzed at a university hospital in the city of Petrolina-PE. The sample comprised patients with a clinical diagnosis of SSI in neurosurgery, using the antibiogram of microbial analyzes. Thus, it was identified that Staphylococcus aureus, a Gram positive bacterium, was the prevalent pathogen in 52.63% of cases. It was found in the findings that the main microorganisms in the infections of the surgical wounds studied were Gram-negative bacteria. Microorganisms showed significant resistance to antibiotic therapy used in the clinical routine. Therefore, the presence of Gram positive cocci and Gram negative bacilli was observed in the SSI in neurosurgery, which proved to be resistant to the tested antimicrobials, including the 3rd generation.